| CQI cycle |  | ||||
---|---|---|---|---|---|---|
Number of women receiving each outcome measure | Baseline n = 829 | End of cycle 1 n = 758 | End of cycle 2 n = 388 | End of cycle 3 n = 135 | End of cycle 4 n = 110 | p-value for trend |
Screened for cigarette use (%) | 603 (73) | 679 (90) | 352 (91) | 125 (93) | 105 (95) | Â |
OR (95Â % CI) | ref | 3.0* (2.2 to 4.1) | 5.1* (3.3 to 7.8) | 6.3* (3.1 to 13) | 11* (4.3 to 29) | n.s. |
OR (95Â % CI) adjusted for mean baseline provisiona | ref | 3.0* (2.2 to 4.1) | 5.2* (3.3 to 8.0) | 6.3* (3.1 to 13) | 11* (4.3 to 29) | n.s. |
Cigarette cessation advice (%) | 185/357 (52) | 280/403 (69) | 161/238 (68) | 63/92 (68) | 49/67 (73) | Â |
OR (95Â % CI) | ref | 2.0* (1.5 to 2.8) | 2.6* (1.7 to 4.0) | 5.8* (3.1 to 11) | 11* (5.2 to 22) | <0.001 |
OR (95Â % CI) adjusted for mean baseline provisiona | ref | 2.1* (1.5 to 2.9) | 2.7* (1.8 to 4.2) | 7.0* (3.7 to 13) | 14* (6.5 to 28) | <0.001 |
Screened for alcohol use (%) | 539 (65) | 633 (84) | 328 (85) | 111 (82) | 91 (83) | Â |
OR (95Â % CI) | ref | 2.6* (2.0 to 3.4) | 3.7* (2.6 to 5.4) | 3.0* (1.7 to 5.1) | 3.8* (2.1 to 6.9) | n.s. |
OR (95Â % CI) adjusted for mean baseline provisiona | ref | 2.6* (2.0 to 3.5) | 3.9* (2.7 to 5.7) | 3.0* (1.8 to 5.2) | 3.9* (2.2 to 7.1) | n.s. |
Brief alcohol counselling (%) | 87/172 (51) | 135/191 (71) | 42/63 (67) | 23/40 (58) | 17/24 (71) | Â |
OR (95Â % CI) | ref | 2.8* (1.7 to 4.6) | 2.0 (1.0 to 4.0) | 2.2 (0.9 to 5.2) | 4.5* (1.6 to 13) | n.s. |
OR (95Â % CI) adjusted for mean baseline provisiona | ref | 2.8 (1.7 to 4.5) | 2.0* (1.0 to 4.1) | 3.1* (1.3 to 7.2) | 6.7* (2.3 to 20) | <0.001 |
Nutrition counselling (%) | 337 (41) | 436 (58) | 227 (59) | 68 (50) | 71 (65) | Â |
OR (95Â % CI) | ref | 1.9* (1.5 to 2.4) | 2.7* (2.0 to 3.6) | 3.5* (2.3 to 5.5) | 8.5* (5.2 to 14) | <0.001 |
OR (95Â % CI) adjusted for mean baseline provisiona | ref | 1.9* (1.5 to 2.4) | 2.7* (2.0 to 3.6) | 3.6* (2.3 to 5.6) | 8.6* (5.2 to 14) | <0.001 |
Food security counselling (%) | 40 (4.8) | 144 (19) | 75 (19) | 16 (12) | 10 (9.1) | Â |
OR (95Â % CI) | ref | 4.6* (3.1 to 7.0) | 3.2* (1.9 to 5.4) | 7.9* (3.5 to 18) | 11* (4.2 to 28) | n.s. |
OR (95Â % CI) adjusted for mean baseline provisiona | ref | 4.6* (3.1 to 7.0) | 3.1* (1.9 to 5.2) | 8.7* (3.8 to 20) | 12* (4.7 to 33) | n.s. |
Physical activity counselling (%) | 162 (20) | 232 (31) | 125 (32) | 30 (22) | 17 (15) | Â |
OR (95Â % CI) | ref | 1.7* (1.3 to 2.2) | 1.9* (1.4 to 2.7) | 3.2* (1.8 to 5.6) | 3.3* (1.7 to 6.5) | <0.001 |
OR (95Â % CI) adjusted for mean baseline provisiona | ref | 1.7* (1.3 to 2.2) | 2.0* (1.4 to 2.8) | 3.9* (2.2 to 6.9) | 4.0* (2.0 to 7.9) | <0.001 |
Folate prescription < 20 weeks (%) | 234 (28) | 329 (43) | 143 (37) | 57 (42) | 37 (34) |  |
OR (95Â % CI) | ref | 2.0* (1.6 to 2.5) | 2.3* (1.7 to 3.2) | 5.3* (3.2 to 8.6) | 4.7* (2.8 to 8.2) | n.s. |
OR (95Â % CI) adjusted for mean baseline provisiona | ref | 2.0* (1.6 to 2.6) | 2.4* (1.7 to 3.3) | 6.0* (3.7 to 9.9) | 5.5* (3.2 to 9.6) | n.s. |